Kidney Res Clin Pract.
2018 Sep;37(3):310-311. 10.23876/j.krcp.2018.37.3.310.
The authors' reply: Use of erythropoiesis-stimulating agents in obese hemodialysis patients
- Affiliations
-
- 1Mansoura Nephrology and Dialysis Unit (MNDU), Faculty of Medicine, Mansoura University, Mansoura, Egypt. ghadakan@mans.edu.eg
- KMID: 2447174
- DOI: http://doi.org/10.23876/j.krcp.2018.37.3.310
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Use of erythropoiesis-stimulating agents in obese hemodialysis patients
- Hemoglobin Variability Associated with Erythropoiesis Stimulating Agents
- Obesity may be erythropoietin dose-saving in hemodialysis patients
- Frequency and Pattern of Hemoglobin Cycling in Korean Hemodialysis Patients Treated with Erythropoiesis Stimulating Agent
- Hemoglobin Variability Associated with Different Erythropoiesis Stimulating Agents in Hemodialysis Patients
